Chickenpox Vaccine Halts Shingles Rise in Young Adults

A large-scale analysis of over 85 million patients in the United States reveals that the chickenpox vaccine may be reversing the trend of increasing shingles cases. Researchers observed a substantial drop in shingles diagnoses among individuals aged 34 and younger between 2019 and 2026. Specifically, rates for 25- to 29-year-olds more than halved, and significant decreases were also noted in the 18- to 24-year-old demographic.

This promising development contrasts with rising shingles rates in individuals aged 35 and older, who are more likely to have contracted chickenpox in childhood. Experts suggest that the near elimination of the virus through vaccination has reduced natural 'boosters' for older individuals, while chronic stress and autoimmune conditions may also contribute to the increase in this group.

While the protective effect of the vaccine is evident in younger populations, it remains to be seen if this protection will last into older age. However, the data strongly suggests potential lifelong benefits from childhood chickenpox vaccination. The varicella vaccine, first approved in 1995 and added to childhood schedules thereafter, has drastically reduced chickenpox infections by 97%.